Abstract
This paper designed a detailed procedure for monogenic hypertension diagnosis by Whole Exome Sequencing (WES) and provided reliable precise medication guidance. Identification of mutated points provides the clinician valuable information for effective individualized therapeutic option. Therapeutic options that specifically restore the pathway disturbed by these point mutations can be selected to give a precise medicinal guidance.